Clinical Trial Packaging Market To Reach $5.46 Billion By 2030

Clinical Trial Packaging Market Growth & Trends

The global clinical trial packaging market size is anticipated to reach USD 5.46 billion by 2030, growing at a CAGR of 10.2% during the forecast period, according to a new report by Grand View Research, Inc. The clinical trial packaging industry is experiencing significant growth, driven by the rising number of clinical trials worldwide. With increasing R&D investments in pharmaceuticals and biologics, demand for specialized packaging solutions has surged. For example, the global clinical trial market is expanding due to advancements in oncology, rare diseases, and personalized medicine, requiring tailored packaging to maintain drug integrity. Additionally, regulatory agencies such as the FDA and EMA mandate stringent packaging standards, further boosting the need for compliant and secure packaging solutions.

The trend toward decentralized clinical trials (DCTs) is also reshaping packaging needs. With more trials conducted remotely, packaging must ensure drug stability during direct-to-patient shipments. For example, temperature-controlled shippers and patient-friendly kits with clear dosing instructions are becoming essential. Companies such as Catalent offer specialized solutions for DCTs, including just-in-time packaging to reduce waste and improve patient adherence. This shift is accelerating due to the COVID-19 pandemic, which highlighted the importance of flexible and resilient supply chains.

Sustainability concerns are influencing packaging strategies. Pharmaceutical companies are adopting eco-friendly materials, such as biodegradable blisters and recyclable secondary packaging, to meet environmental regulations and corporate sustainability goals. For instance, in April 2023, MAX Solutions introduced MAX Ecoblister, an innovative, eco-friendly alternative to traditional plastic blister packaging that combines a recyclable fiber top card with a compostable PaperFoam tray, offering brands a sustainable, turnkey solution that maintains high functionality and aesthetic appeal while eliminating plastic use.

Furthermore, the market for clinical trial packaging is dominated by North America, particularly the U.S., due to its robust pharmaceutical R&D ecosystem, high number of clinical trials, and stringent regulatory requirements from the FDA. Europe follows closely, driven by strong biopharmaceutical innovation in countries such as Germany, the UK, and Switzerland, along with EMA regulations emphasizing patient safety and packaging integrity. The Asia-Pacific (APAC) region is the fastest-growing market, fueled by increasing clinical trial outsourcing to countries such as India and China, cost advantages, and expanding healthcare infrastructure.

 Request a free sample copy or view report summary: Clinical Trial Packaging Market Report

Clinical Trial Packaging Market Report Highlights

• The plastic material segment accounted for the largest market share of over 53.0% in 2024.

• The metal material segment is expected to grow at the fastest CAGR of 11.1% during the forecast period.

• The vials & ampoules product segment accounted for the largest market share of over 31.0% in 2024 and is projected to grow at the fastest CAGR of 10.8% during the forecast period.

• Based on end use, the research laboratories segment dominated the clinical trial packaging industry in 2024 with the largest revenue share of over 51.0%.

• The clinical research organizations segment is expected to grow at the fastest CAGR of 10.8% over the forecast period of 2025 to 2030.

• North America dominated the regional market with the largest revenue share of over 37.0% in 2024.

• Asia Pacific is projected to grow at the fastest CAGR of 10.8% over the forecast period of 2025 to 2030.

• In February 2023, Gerresheimer AG introduced its new Clinical Trial Kit at Pharmapack in Paris, designed to accelerate drug development by providing a complete set of sterile Gx RTF vials in nest and tub or tray with matching closures, specifically tailored for early-phase development of new drugs, vaccines, and biologics.

Clinical Trial Packaging Market Segmentation

Grand View Research has segmented the global clinical trial packaging market based on material, product, end use, and region:

Clinical Trial Packaging Material Outlook (Revenue, USD Million, 2018 - 2030)

• Plastic

• Glass

• Metal

• Paper & Corrugated Fiber

Clinical Trial Packaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• Syringes

• Vials & Ampoules

• Bottles

• Bags & Pouches

• Others

Clinical Trial Packaging End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Research Laboratories

• Clinical Research Organizations

• Drug Manufacturing Facilities

Clinical Trial Packaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in the Clinical Trial Packaging Market

• Thermo Fisher Scientific Inc.

• Clinigen Limited

• PCI Pharma Services

• Yourway

• WestRock Company

• Oliver

• CCL Industries Inc.

• Sharp Services, LLC

• SCHOTT Pharma

• Gerresheimer AG

• Borosil Scientific

• Nipro